S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

INVO INVO BioScience Inc

0.833

0.00 (0.00%)

Pre Market

Last Updated: 11:00:00

Delayed by 15 minutes

Form S-4 - Registration of securities, business combinations

0001493152-24-002505.txt

INVO BioScience (NASDAQ:INVO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more INVO BioScience Charts.

INVO BioScience (NASDAQ:INVO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more INVO BioScience Charts.

INVO BioScience Inc News

NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
Friday 25 October 2024 (3 months ago) • GlobeNewswire Inc.

Form RW - Registration Withdrawal Request
Wednesday 23 October 2024 (3 months ago) • Edgar (US Regulatory)

INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 16 October 2024 (3 months ago) • Edgar (US Regulatory)

INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
Tuesday 15 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 2 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 21 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (5 months ago) • Edgar (US Regulatory)

INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
Wednesday 14 August 2024 (5 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 22 May 2024 (8 months ago) • Edgar (US Regulatory)

More INVO BioScience Inc News Articles

Xtrackers Msci Emu Esg U...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions